Manejo de la dislipemia aterogénica en Atención Primariadescripción de la práctica clínica habitual (Estudio Avanza)

  1. Capón Álvarez, Jessica
Dirixida por:
  1. Jesús Seco Calvo Director
  2. Ángel Díaz Rodríguez Director

Universidade de defensa: Universidad de León

Fecha de defensa: 28 de xaneiro de 2021

Tribunal:
  1. José L. Mauriz Presidente
  2. Vicente Rodríguez Pérez Secretario
  3. Luis Alberto Rodríguez Arroyo Vogal

Tipo: Tese

Teseo: 649613 DIALNET lock_openBULERIA editor

Resumo

Atherogenic Dyslipemia (DA) is an alteration of lipid and lipoprotein metabolism. It is characterized by the presence of low levels of cholesterol transported by high density lipoproteins (HDL), hypertriglyceridemia and a high proportion of LDL (LDL: low density lipoproteins) small and dense, with or without a moderate increase in cLDL. This type of dyslipemia is associated with a high cardiovascular risk and contributes significantly to lipid residual vascular risk. It is also a very common lipoprotic phenotype and is associated with obesity, insulin resistance, coronary heart disease, metabolic syndrome, or type 21 diabetes mellitus (DM) .